TNF and urinary bladder cancer: Agarwal et al. [32] have reported that mean levels of TNF-α were also significantly reduced in pretherapeutic serum samples of patients with bladder cancer as compared to the controls, whereas Gendek-Kubiak et al. [33] showed that the average TNF-α levels measured in neoplastic patients were not significantly different from that observed in the control group.